Assessing and Mitigating Local Vulnerabilities to Completeness of Global Polio Eradication.
作者信息
Bandyopadhyay Ananda S, Orenstein Walter A
机构信息
Polio, Global Development Division, Bill & Melinda Gates Foundation, Seattle, Washington, USA.
Department of Medicine, Emory University, Atlanta, Georgia, USA.
出版信息
J Pediatric Infect Dis Soc. 2022 Jan 27;11(1):3-4. doi: 10.1093/jpids/piab102.
Abstract
摘要
相似文献
1
Assessing and Mitigating Local Vulnerabilities to Completeness of Global Polio Eradication.评估并减轻全球消灭脊髓灰质炎工作中地方层面的薄弱环节对工作完整性的影响。
J Pediatric Infect Dis Soc. 2022 Jan 27;11(1):3-4. doi: 10.1093/jpids/piab102.
2
Global polio eradication: not there yet.全球消灭脊髓灰质炎：尚未成功。
Lancet. 2013 Jan 5;381(9860):1. doi: 10.1016/S0140-6736(13)60002-1.
3
Pakistan: the final frontier for global polio eradication.巴基斯坦：全球根除脊髓灰质炎的最后堡垒。
J Epidemiol Community Health. 2016 Feb;70(2):109-10. doi: 10.1136/jech-2015-205530. Epub 2015 Aug 1.
4
Polio eradication - just one final sprint to the finish.根除脊髓灰质炎——只需向终点冲刺最后一程。
Tidsskr Nor Laegeforen. 2018 Mar 5;138(5). doi: 10.4045/tidsskr.18.0196. Print 2018 Mar 6.
5
Polio eradication: falling at the final hurdle?根除脊髓灰质炎：在最后一道难关前折戟？
Lancet. 2022 Oct 1;400(10358):1079. doi: 10.1016/S0140-6736(22)01875-X.
6
Polio eradication efforts: Above all, do no harm.
Science. 2023 Nov 17;382(6672):778. doi: 10.1126/science.adl2371. Epub 2023 Nov 16.
7
After polio: Imagining, planning, and delivering a world beyond eradication.脊髓灰质炎后：想象、规划和打造一个无脊髓灰质炎的世界。
Health Place. 2018 Nov;54:29-36. doi: 10.1016/j.healthplace.2018.09.006. Epub 2018 Sep 18.
8
Progress towards the global eradication of poliomyelitis.全球根除脊髓灰质炎的进展。
World Health Stat Q. 1992;45(2-3):280-4.
9
How to avoid causing polio in the name of its eradication.如何避免在根除脊髓灰质炎的名义下引发脊髓灰质炎。
Lancet. 2023 Jul 15;402(10397):179-180. doi: 10.1016/S0140-6736(23)01069-3.
10
Polio eradication challenges in Pakistan.巴基斯坦的脊髓灰质炎根除挑战。
Clin Microbiol Infect. 2018 Jan;24(1):6-7. doi: 10.1016/j.cmi.2017.09.008. Epub 2017 Sep 28.
本文引用的文献
1
A Survey to Assess Serological Prevalence of Poliovirus Antibodies in Areas With High-Risk for Vaccine-Derived Poliovirus Transmission in Chad.乍得高危疫苗衍生脊灰病毒传播地区血清脊灰病毒抗体的评估调查。
J Pediatric Infect Dis Soc. 2022 Feb 23;11(2):55-59. doi: 10.1093/jpids/piab103.
2
Immunogenicity of Fractional Dose Inactivated Poliovirus Vaccine in India.印度小剂量灭活脊髓灰质炎疫苗的免疫原性。
J Pediatric Infect Dis Soc. 2022 Feb 23;11(2):60-68. doi: 10.1093/jpids/piab091.
3
Fractional dose compared with standard dose inactivated poliovirus vaccine in children: a systematic review and meta-analysis.分剂量与标准剂量灭活脊髓灰质炎疫苗在儿童中的比较：系统评价和荟萃分析。
Lancet Infect Dis. 2021 Aug;21(8):1161-1174. doi: 10.1016/S1473-3099(20)30693-9. Epub 2021 Apr 30.
4
Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trial.在消灭脊灰病毒后时代，不同灭活脊灰病毒疫苗接种方案的安全性和免疫原性：一项随机、开放标签、多中心、3 期、非劣效性试验。
Lancet Infect Dis. 2021 Apr;21(4):559-568. doi: 10.1016/S1473-3099(20)30555-7. Epub 2020 Oct 23.
5
Final frontiers of the polio eradication endgame.脊髓灰质炎根除终局的最后前沿。
Curr Opin Infect Dis. 2020 Oct;33(5):404-410. doi: 10.1097/QCO.0000000000000667.
6
The Immunogenicity of Fractional Intradermal Doses of the Inactivated Poliovirus Vaccine Is Associated With the Size of the Intradermal Fluid Bleb.皮内剂量的脊髓灰质炎病毒灭活疫苗的免疫原性与皮内液疱的大小有关。
Clin Infect Dis. 2017 Sep 1;65(5):851-854. doi: 10.1093/cid/cix381.
Zotero 插件